Scotland · NHS Scotland MSAN
Buprenorphine/naloxone (Suboxone®) 2mg/500microgram and 8mg/2mg
MSAN(2026)4 · Level 2 · issued 16 Jan 2026
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| Valid until: product has been discontinued | Discontinued | — |
| were discontinued on 5th January 2026. | Discontinued | — |
| available but future supply to the UK is to be confirmed. | Resupply date to be confirmed | — |
| lyophilisate 2mg and 8mg (Espranor®) remain available. | Available | — |
| you need to register with the SPS website. Registration for access to the website is available to | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.